FTC sues key pharmacy benefit professionals above insulin prices The agency introduced action versus Caremark, Categorical Scripts and Optum Rx, arguing their “anticompetitive and unfair” rebating tactics “artificially inflated” the list price of life-saving insulin medication. Insurers will keep on vertically integrating to maintain a lot more profits in-household, and https://arizonahardteanutritionfa26150.full-design.com/about-healthcare-news-73266263